Novartis
NVS
NVS
1,306 hedge funds and large institutions have $15.2B invested in Novartis in 2024 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 413 increasing their positions, 478 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
13% less funds holding in top 10
Funds holding in top 10: 15 → 13 (-2)
14% less repeat investments, than reductions
Existing positions increased: 413 | Existing positions reduced: 478
42% less call options, than puts
Call options by funds: $171M | Put options by funds: $294M
Holders
1,306
Holding in Top 10
13
Calls
$171M
Puts
$294M
Top Buyers
| 1 | +$78.8M | |
| 2 | +$46.6M | |
| 3 | +$36.6M | |
| 4 |
Fisher Asset Management
Camas,
Washington
|
+$26.7M |
| 5 |
MIF
Mediolanum International Funds
Dublin 1,
Ireland
|
+$24.1M |
Top Sellers
| 1 | -$139M | |
| 2 | -$132M | |
| 3 | -$112M | |
| 4 |
CCM
Cullen Capital Management
New York
|
-$71.1M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$64.6M |